Thyroid Eye Disease TED Market SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Thyroid Eye Disease (TED) Market is segmented By Drug Type (Biologics, Small Molecules, Others), By Treatment Type (Monotherapy, Combination Therapy), By Route of Administration (Oral, Intravenous, Subcutaneous), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.
Thyroid Eye Disease TED Market Size
Market Size in USD
CAGR5.9%
| Study Period | 2024 - 2031 |
| Base Year of Estimation | 2023 |
| CAGR | 5.9% |
| Market Concentration | High |
| Major Players | Horizon Therapeutics, Immunovant, Viridian Therapeutics, Novartis, Apitope |
please let us know !
Thyroid Eye Disease TED Market Analysis
The Global Thyroid Eye Disease (TED) Market is estimated to be valued at USD 2.55 Billion in 2024 and is expected to reach USD 3.91 Billion by 2031, growing at a compound annual growth rate (CAGR) of 5.9% from 2024 to 2031. The increasing prevalence of Graves' disease and hyperthyroidism across the globe is expected to drive the market growth during the forecast period.
The rising awareness about the condition and its treatment options along with increasing healthcare expenditure is further augmenting the market growth. Additionally, the expanding R&D activities for development of novel drug candidates for treatment of TED is also contributing to the increasing demand. Various pharmaceutical companies are investing heavily in clinical trials to develop effective therapeutic solutions for better management of TED symptoms.